*Terms and conditions apply. Visit Nada's website for more details. Kamala Harris, the U.S. Democratic candidate, made headlines Tuesday when she told a group of Black journalists that, if elected ...

Analysts have recently evaluated ADMA Biologics and provided 12-month price targets. The average target is $18.25, ...

Gartner IT has outperformed the market over the past 15 years by 13.06% on an annualized basis producing an average annual ...

Jim Cramer, the host of CNBC’s “Mad Money,” is known for his energetic and often controversial takes on the stock market.

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock. This data can help you ...

Novo Nordisk announced positive Phase 2a trial results for monlunabant, showing significant weight loss with a 10 mg dose.

A study reveals the potential use of cannabis in biblical times, suggesting Jesus used it for healing and anointing practices ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $43.8, a high estimate of $46.00 ...

Analysts have set 12-month price targets for Ultragenyx Pharmaceutical, revealing an average target of $89.7, a high estimate ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $318.33, ...

NovaBay shares are trading higher after the company announced it reached a definitive agreement to sell its Avenova assets ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...